Quick Answer
TuHURA Biosciences, Inc./NV reported Diluted EPS of $0.63 per share (loss) for fiscal year 2025.
TuHURA Biosciences, Inc./NV Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.63 | +47.9% |
| 2024 | -$1.21 | +51.0% |
| 2023 | -$2.47 | -2000.0% |
| 2015 | $0.13 | — |
| 2014 | $0.00 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.14 | +74.1% | +33.3% |
| June 30, 2025 | -$0.21 | +51.2% | -40.0% |
| March 31, 2025 | -$0.15 | +62.5% | +72.2% |
| September 30, 2024 | -$0.54 | — | -25.6% |
| June 30, 2024 | -$0.43 | — | -7.5% |
| March 31, 2024 | -$0.40 | — | -1100.0% |
| March 31, 2015 | $0.04 | -60.0% | +33.3% |
| December 31, 2014 | $0.03 | +0.0% | -25.0% |
- TuHURA Biosciences, Inc./NV showed an increase of +47.9% in Diluted EPS compared to the prior fiscal year.
- The most recent figure is from TuHURA Biosciences, Inc./NV’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: